Efficacy of medication abortion with concurrent initiation of progestin contraceptives: A retrospective cohort study.

ABSTRACT:

Objectives

To evaluate medication abortion (MAB) outcomes for participants receiving intramuscular depot medroxyprogesterone acetate (DMPA) injections or subdermal etonogestrel implants concurrently with mifepristone compared to those who did not in a real-world setting.

Study design

This retrospective cohort study included MAB patients from one Planned Parenthood health center in St. Paul, MN, between 2017 and 2019. We abstracted electronic health records and compared sociodemographic variables, clinical information, and treatment failure rates (primary outcome) between study groups with logistic regression (generating odds ratios [OR] and 95% confidence intervals [CI]).

Results

Among 7296 MAB participants, 224 (3.1%) received DMPA injections and 309 (4.2%) received

SUBMITTER: Carroll AL 

PROVIDER: S-EPMC11588561 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature